ArticleOPEN ACCESS

Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance

Blood Cancer Journal
DOI: 10.1038/s41408-023-00898-4
11Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Khan, I., Kaempf, A., Raghuwanshi, S., Chesnokov, M., Zhang, X., Wang, Z., … Gartel, A. L. (2023, December 1). Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance. Blood Cancer Journal. Springer Nature. https://doi.org/10.1038/s41408-023-00898-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free